VC  Longevity Vision Fund

     Office Locations:

555 Madison Avenue, 5th Fl.
New York, NY 10022
Phone: 917-573-3282



  • Early
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    Longevity Vision Fund is a $100M life extension-focused investment fund dedicated to making longevity affordable and accessible to all. Founded by Sergey Young, the fund accelerates breakthroughs in longevity by investing in start-ups and companies that develop technologies, products, and services that extend human lifespans and overcome the negative effects of aging. The Fund provides Seed to Series C funding to biotech and life extension-focused companies developing early diagnostics, AI in healthcare, and therapies addressing age-related diseases.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Avik Arakelyan Head of Investments
    Sergey Young Founder


    Recent Funding Events (trailing 12 months):







      Exo Imaging



      Series B Extension


      Sigilon Therapeutics



      Series B





      Convertible Debt


    Portfolio companies include:

      4D Molecular Therapeutics
        web link

      Exo Imaging
        web link

        web link

      Insilico Medicine
        web link

        web link

      Life Biosciences
        web link

        web link

      Sigilon Therapeutics
        web link


    Recent News: